申请人:Hoffmann-La Roche Inc.
公开号:US05298652A1
公开(公告)日:1994-03-29
Compounds of the formula ##STR1## R is hydrogen or --CH.sub.2 COOH; m is 0-2, x is 1-2, with the provision that when x is 2, m is always 0; R.sub.1 is CH.sub.3 (CH.sub.2).sub.n O--, CH.sub.3 (CH.sub.2).sub.n CONH--, CH.sub.3 (CH.sub.2).sub.n NHCONH--, CH.sub.3 (CH.sub.2).sub.n NHCOO--, HOOC(CH.sub.2).sub.p O-- or R.sub.3 (CH.sub.2).sub.q O--; R.sub.2 is hydrogen, carboxy, hydroxy, nitro, amino, CH.sub.3 (CH.sub.2).sub.n O--, CH.sub.3 (CH.sub.2).sub.n CONH--, CH.sub.3 (CH.sub.2).sub.n NHCONH--, CH.sub.3 (CH.sub.2).sub.n NHCOO--, HOOC(CH.sub.2).sub.p O--, R.sub.3 (CH.sub.2).sub.q O-- or R.sub.4 [O(CH.sub.2).sub.2 ].sub.r O--, wherein n is 0-17, p is 1-10, q is 1-12, r is 1-6, R.sub.3 is 1- or 2- naphthyloxy, 2,3- or 3,4-dihydroxyphenyl, phenyl, phenoxy or substituted phenyl or phenoxy, wherein the substituent is selected from the group consisting of lower alkyl, lower alkoxy, hydroxy, nitro, amino, halo, carboxy or phenyl, and R.sub.4 is lower alkyl; and pharmaceutically acceptable salts with bases, are described.
式为##STR1##的化合物;R为氢或--CH.sub.2 COOH;m为0-2,x为1-2,但当x为2时,m始终为0;R.sub.1为CH.sub.3 (CH.sub.2).sub.n O--,CH.sub.3 (CH.sub.2).sub.n CONH--,CH.sub.3 (CH.sub.2).sub.n NHCONH--,CH.sub.3 (CH.sub.2).sub.n NHCOO--,HOOC(CH.sub.2).sub.p O--或R.sub.3 (CH.sub.2).sub.q O--;R.sub.2为氢,羧基,羟基,硝基,氨基,CH.sub.3 (CH.sub.2).sub.n O--,CH.sub.3 (CH.sub.2).sub.n CONH--,CH.sub.3 (CH.sub.2).sub.n NHCONH--,CH.sub.3 (CH.sub.2).sub.n NHCOO--,HOOC(CH.sub.2).sub.p O--,R.sub.3 (CH.sub.2).sub.q O--或R.sub.4 [O(CH.sub.2).sub.2 ].sub.r O--,其中n为0-17,p为1-10,q为1-12,r为1-6,R.sub.3为1-或2-萘氧基,2,3-或3,4-二羟基苯基,苯基,苯氧基或取代苯基或苯氧基,其中取代基选自较低的烷基,较低的烷氧基,羟基,硝基,氨基,卤素,羧基或苯基,R.sub.4为较低的烷基;以及与碱形成的药学上可接受的盐。